Osthole regulates N6‐methyladenosine‐modified TGM2 to inhibit the progression of rheumatoid arthritis and associated interstitial lung disease
Abstract Rheumatoid arthritis (RA) is an inflammatory autoimmune disease, and RA interstitial lung disease (ILD) is a severe complication of RA. This investigation aims to determine the effect and underlying mechanism of osthole (OS), which could be extracted from Cnidium, Angelica, and Citrus plant...
Saved in:
Main Authors: | Xian Lin, Jian Chen, Cheng Tao, Lianxiang Luo, Juan He, Qingwen Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Warrick score in rheumatoid-arthritis interstitial lung disease: a promising tool for assessing the extent and progression of lung involvement
by: Duygu Temiz Karadag, et al.
Published: (2025-01-01) -
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?
by: Beatrice Maranini, et al.
Published: (2025-01-01) -
Neutrophil extracellular traps (NETs) are increased in rheumatoid arthritis-associated interstitial lung disease
by: Jing Xue, et al.
Published: (2025-01-01) -
Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond
by: Elpida Neofotistou-Themeli, et al.
Published: (2025-01-01) -
Efficacy and safety of conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-interstitial lung disease: A narrative review
by: Richard Conway, et al.
Published: (2021-01-01)